 | • レポートコード：QFJ1-4990 • 出版社/出版日：QYResearch / 2021年6月 ※2024年版があります。お問い合わせください。 • レポート形態：英文、PDF、119ページ • 納品方法：Eメール（納期：3日） • 産業分類：医療 |
| Single User | ￥577,200 (USD3,900) | ▷ お問い合わせ |
| Multi User | ￥865,800 (USD5,850) | ▷ お問い合わせ |
• お支払方法：銀行振込（納品後、ご請求書送付）
レポート概要
| QYResearch社発行の本調査レポートでは、腫瘍ゲノミクスの世界市場（2016年～2027年）を対象に調査し、市場動向、主要企業の市場シェア、種類別市場規模（アッセイ＆キット、機器）、用途別市場規模（診断＆モニタリング、創薬＆開発、バイオマーカー発見）、主要地域別市場規模（北米、アメリカ、欧州、アジア、日本、中国、韓国、インド、東南アジア、中南米、中東、アフリカ等）、企業情報などをまとめております。 ・市場概要 ・腫瘍ゲノミクスの市場動向 ・企業の競争状況、市場シェア ・腫瘍ゲノミクスの種類別市場規模と予測2016-2027（アッセイ＆キット、機器） ・腫瘍ゲノミクスの用途別市場規模と予測2016-2027（診断＆モニタリング、創薬＆開発、バイオマーカー発見） ・腫瘍ゲノミクスの北米市場規模2016-2027（アメリカ、カナダ） ・腫瘍ゲノミクスの欧州市場規模2016-2027（ドイツ、フランス、イギリス等） ・腫瘍ゲノミクスのアジア市場規模2016-2027（日本、中国、韓国、インド、東南アジア等） ・腫瘍ゲノミクスの中南米市場規模2016-2027（メキシコ、ブラジル） ・腫瘍ゲノミクスの中東・アフリカ市場規模2016-2027（トルコ、サウジアラビア等） ・主要企業情報（Abbott Laboratories、Agilent Technologies, Inc、Bio-Rad Laboratories, Inc.、Danaher Corporation、F. Hoffmann-La Roche Ltd、Fluidigm Corporation、General Electric Company、Illumina, Inc.、Merck KGaA、Myriad Genetics, Inc.、Pacific Biosciences of California, Inc.、PerkinElmer、QIAGEN、Siemens Healthineers AG、Thermo Fisher Scientific Inc.） ・結論 |
Tumor genomics, also known as cancer genomics, is an emerging sub-discipline in genomics, mainly through the high-throughput sequencing technology to associate genes with cancer. Tumor is a disease caused by the accumulation of DNA mutations that leads to an uncontrolled proliferation of cells and the formation of new organisms. The main goal of tumor genomics is to provide new methods for tumor diagnosis, tumor clinical outcome prediction and tumor target treatment by identifying new oncogenes or tumor suppressor genes.
Market Analysis and Insights: Global Tumor Genomics Market
The global Tumor Genomics market size is projected to reach US$ XX million by 2027, from US$ XX million in 2020, at a CAGR of XX% during 2021-2027.
With industry-standard accuracy in analysis and high data integrity, the report makes a brilliant attempt to unveil key opportunities available in the global Tumor Genomics market to help players in achieving a strong market position. Buyers of the report can access verified and reliable market forecasts, including those for the overall size of the global Tumor Genomics market in terms of revenue.
On the whole, the report proves to be an effective tool that players can use to gain a competitive edge over their competitors and ensure lasting success in the global Tumor Genomics market. All of the findings, data, and information provided in the report are validated and revalidated with the help of trustworthy sources. The analysts who have authored the report took a unique and industry-best research and analysis approach for an in-depth study of the global Tumor Genomics market.
Global Tumor Genomics Scope and Market Size
Tumor Genomics market is segmented by company, region (country), by Type, and by Application. Players, stakeholders, and other participants in the global Tumor Genomics market will be able to gain the upper hand as they use the report as a powerful resource. The segmental analysis focuses on revenue and forecast by Type and by Application in terms of revenue and forecast for the period 2016-2027.
Segment by Type
Assays and Kits
Instrument
Segment by Application
Diagnostics and Monitoring
Drug Discovery and Development
Biomarker Discovery
By Region
North America
United States
Canada
Europe
Germany
France
U.K.
Italy
Russia
Nordic
Rest of Europe
Asia-Pacific
China
Japan
South Korea
Southeast Asia
India
Australia
Rest of Asia
Latin America
Mexico
Brazil
Rest of Latin America
Middle East & Africa
Turkey
Saudi Arabia
UAE
Rest of MEA
By Company
Abbott Laboratories
Agilent Technologies, Inc
Bio-Rad Laboratories, Inc.
Danaher Corporation
F. Hoffmann-La Roche Ltd
Fluidigm Corporation
General Electric Company
Illumina, Inc.
Merck KGaA
Myriad Genetics, Inc.
Pacific Biosciences of California, Inc.
PerkinElmer
QIAGEN
Siemens Healthineers AG
Thermo Fisher Scientific Inc.
1 Report Overview
1.1 Study Scope
1.2 Market Analysis by Type
1.2.1 Global Tumor Genomics Market Size Growth Rate by Type: 2016 VS 2021 VS 2027
1.2.2 Assays and Kits
1.2.3 Instrument
1.3 Market by Application
1.3.1 Global Tumor Genomics Market Share by Application: 2016 VS 2021 VS 2027
1.3.2 Diagnostics and Monitoring
1.3.3 Drug Discovery and Development
1.3.4 Biomarker Discovery
1.4 Study Objectives
1.5 Years Considered
2 Global Growth Trends
2.1 Global Tumor Genomics Market Perspective (2016-2027)
2.2 Tumor Genomics Growth Trends by Regions
2.2.1 Tumor Genomics Market Size by Regions: 2016 VS 2021 VS 2027
2.2.2 Tumor Genomics Historic Market Share by Regions (2016-2021)
2.2.3 Tumor Genomics Forecasted Market Size by Regions (2022-2027)
2.3 Tumor Genomics Industry Dynamic
2.3.1 Tumor Genomics Market Trends
2.3.2 Tumor Genomics Market Drivers
2.3.3 Tumor Genomics Market Challenges
2.3.4 Tumor Genomics Market Restraints
3 Competition Landscape by Key Players
3.1 Global Top Tumor Genomics Players by Revenue
3.1.1 Global Top Tumor Genomics Players by Revenue (2016-2021)
3.1.2 Global Tumor Genomics Revenue Market Share by Players (2016-2021)
3.2 Global Tumor Genomics Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
3.3 Players Covered: Ranking by Tumor Genomics Revenue
3.4 Global Tumor Genomics Market Concentration Ratio
3.4.1 Global Tumor Genomics Market Concentration Ratio (CR5 and HHI)
3.4.2 Global Top 10 and Top 5 Companies by Tumor Genomics Revenue in 2020
3.5 Tumor Genomics Key Players Head office and Area Served
3.6 Key Players Tumor Genomics Product Solution and Service
3.7 Date of Enter into Tumor Genomics Market
3.8 Mergers & Acquisitions, Expansion Plans
4 Tumor Genomics Breakdown Data by Type
4.1 Global Tumor Genomics Historic Market Size by Type (2016-2021)
4.2 Global Tumor Genomics Forecasted Market Size by Type (2022-2027)
5 Tumor Genomics Breakdown Data by Application
5.1 Global Tumor Genomics Historic Market Size by Application (2016-2021)
5.2 Global Tumor Genomics Forecasted Market Size by Application (2022-2027)
6 North America
6.1 North America Tumor Genomics Market Size (2016-2027)
6.2 North America Tumor Genomics Market Size by Type
6.2.1 North America Tumor Genomics Market Size by Type (2016-2021)
6.2.2 North America Tumor Genomics Market Size by Type (2022-2027)
6.2.3 North America Tumor Genomics Market Size by Type (2016-2027)
6.3 North America Tumor Genomics Market Size by Application
6.3.1 North America Tumor Genomics Market Size by Application (2016-2021)
6.3.2 North America Tumor Genomics Market Size by Application (2022-2027)
6.3.3 North America Tumor Genomics Market Size by Application (2016-2027)
6.4 North America Tumor Genomics Market Size by Country
6.4.1 North America Tumor Genomics Market Size by Country (2016-2021)
6.4.2 North America Tumor Genomics Market Size by Country (2022-2027)
6.4.3 United States
6.4.4 Canada
7 Europe
7.1 Europe Tumor Genomics Market Size (2016-2027)
7.2 Europe Tumor Genomics Market Size by Type
7.2.1 Europe Tumor Genomics Market Size by Type (2016-2021)
7.2.2 Europe Tumor Genomics Market Size by Type (2022-2027)
7.2.3 Europe Tumor Genomics Market Size by Type (2016-2027)
7.3 Europe Tumor Genomics Market Size by Application
7.3.1 Europe Tumor Genomics Market Size by Application (2016-2021)
7.3.2 Europe Tumor Genomics Market Size by Application (2022-2027)
7.3.3 Europe Tumor Genomics Market Size by Application (2016-2027)
7.4 Europe Tumor Genomics Market Size by Country
7.4.1 Europe Tumor Genomics Market Size by Country (2016-2021)
7.4.2 Europe Tumor Genomics Market Size by Country (2022-2027)
7.4.3 Germany
7.4.4 France
7.4.5 U.K.
7.4.6 Italy
7.4.7 Russia
7.4.8 Nordic
8 Asia-Pacific
8.1 Asia-Pacific Tumor Genomics Market Size (2016-2027)
8.2 Asia-Pacific Tumor Genomics Market Size by Type
8.2.1 Asia-Pacific Tumor Genomics Market Size by Type (2016-2021)
8.2.2 Asia-Pacific Tumor Genomics Market Size by Type (2022-2027)
8.2.3 Asia-Pacific Tumor Genomics Market Size by Type (2016-2027)
8.3 Asia-Pacific Tumor Genomics Market Size by Application
8.3.1 Asia-Pacific Tumor Genomics Market Size by Application (2016-2021)
8.3.2 Asia-Pacific Tumor Genomics Market Size by Application (2022-2027)
8.3.3 Asia-Pacific Tumor Genomics Market Size by Application (2016-2027)
8.4 Asia-Pacific Tumor Genomics Market Size by Region
8.4.1 Asia-Pacific Tumor Genomics Market Size by Region (2016-2021)
8.4.2 Asia-Pacific Tumor Genomics Market Size by Region (2022-2027)
8.4.3 China
8.4.4 Japan
8.4.5 South Korea
8.4.6 Southeast Asia
8.4.7 India
8.4.8 Australia
9 Latin America
9.1 Latin America Tumor Genomics Market Size (2016-2027)
9.2 Latin America Tumor Genomics Market Size by Type
9.2.1 Latin America Tumor Genomics Market Size by Type (2016-2021)
9.2.2 Latin America Tumor Genomics Market Size by Type (2022-2027)
9.2.3 Latin America Tumor Genomics Market Size by Type (2016-2027)
9.3 Latin America Tumor Genomics Market Size by Application
9.3.1 Latin America Tumor Genomics Market Size by Application (2016-2021)
9.3.2 Latin America Tumor Genomics Market Size by Application (2022-2027)
9.3.3 Latin America Tumor Genomics Market Size by Application (2016-2027)
9.4 Latin America Tumor Genomics Market Size by Country
9.4.1 Latin America Tumor Genomics Market Size by Country (2016-2021)
9.4.2 Latin America Tumor Genomics Market Size by Country (2022-2027)
9.4.3 Mexico
9.4.4 Brazil
10 Middle East & Africa
10.1 Middle East & Africa Tumor Genomics Market Size (2016-2027)
10.2 Middle East & Africa Tumor Genomics Market Size by Type
10.2.1 Middle East & Africa Tumor Genomics Market Size by Type (2016-2021)
10.2.2 Middle East & Africa Tumor Genomics Market Size by Type (2022-2027)
10.2.3 Middle East & Africa Tumor Genomics Market Size by Type (2016-2027)
10.3 Middle East & Africa Tumor Genomics Market Size by Application
10.3.1 Middle East & Africa Tumor Genomics Market Size by Application (2016-2021)
10.3.2 Middle East & Africa Tumor Genomics Market Size by Application (2022-2027)
10.3.3 Middle East & Africa Tumor Genomics Market Size by Application (2016-2027)
10.4 Middle East & Africa Tumor Genomics Market Size by Country
10.4.1 Middle East & Africa Tumor Genomics Market Size by Country (2016-2021)
10.4.2 Middle East & Africa Tumor Genomics Market Size by Country (2022-2027)
10.4.3 Turkey
10.4.4 Saudi Arabia
10.4.5 UAE
11 Key Players Profiles
11.1 Abbott Laboratories
11.1.1 Abbott Laboratories Company Details
11.1.2 Abbott Laboratories Business Overview
11.1.3 Abbott Laboratories Tumor Genomics Introduction
11.1.4 Abbott Laboratories Revenue in Tumor Genomics Business (2016-2021)
11.1.5 Abbott Laboratories Recent Development
11.2 Agilent Technologies, Inc
11.2.1 Agilent Technologies, Inc Company Details
11.2.2 Agilent Technologies, Inc Business Overview
11.2.3 Agilent Technologies, Inc Tumor Genomics Introduction
11.2.4 Agilent Technologies, Inc Revenue in Tumor Genomics Business (2016-2021)
11.2.5 Agilent Technologies, Inc Recent Development
11.3 Bio-Rad Laboratories, Inc.
11.3.1 Bio-Rad Laboratories, Inc. Company Details
11.3.2 Bio-Rad Laboratories, Inc. Business Overview
11.3.3 Bio-Rad Laboratories, Inc. Tumor Genomics Introduction
11.3.4 Bio-Rad Laboratories, Inc. Revenue in Tumor Genomics Business (2016-2021)
11.3.5 Bio-Rad Laboratories, Inc. Recent Development
11.4 Danaher Corporation
11.4.1 Danaher Corporation Company Details
11.4.2 Danaher Corporation Business Overview
11.4.3 Danaher Corporation Tumor Genomics Introduction
11.4.4 Danaher Corporation Revenue in Tumor Genomics Business (2016-2021)
11.4.5 Danaher Corporation Recent Development
11.5 F. Hoffmann-La Roche Ltd
11.5.1 F. Hoffmann-La Roche Ltd Company Details
11.5.2 F. Hoffmann-La Roche Ltd Business Overview
11.5.3 F. Hoffmann-La Roche Ltd Tumor Genomics Introduction
11.5.4 F. Hoffmann-La Roche Ltd Revenue in Tumor Genomics Business (2016-2021)
11.5.5 F. Hoffmann-La Roche Ltd Recent Development
11.6 Fluidigm Corporation
11.6.1 Fluidigm Corporation Company Details
11.6.2 Fluidigm Corporation Business Overview
11.6.3 Fluidigm Corporation Tumor Genomics Introduction
11.6.4 Fluidigm Corporation Revenue in Tumor Genomics Business (2016-2021)
11.6.5 Fluidigm Corporation Recent Development
11.7 General Electric Company
11.7.1 General Electric Company Company Details
11.7.2 General Electric Company Business Overview
11.7.3 General Electric Company Tumor Genomics Introduction
11.7.4 General Electric Company Revenue in Tumor Genomics Business (2016-2021)
11.7.5 General Electric Company Recent Development
11.8 Illumina, Inc.
11.8.1 Illumina, Inc. Company Details
11.8.2 Illumina, Inc. Business Overview
11.8.3 Illumina, Inc. Tumor Genomics Introduction
11.8.4 Illumina, Inc. Revenue in Tumor Genomics Business (2016-2021)
11.8.5 Illumina, Inc. Recent Development
11.9 Merck KGaA
11.9.1 Merck KGaA Company Details
11.9.2 Merck KGaA Business Overview
11.9.3 Merck KGaA Tumor Genomics Introduction
11.9.4 Merck KGaA Revenue in Tumor Genomics Business (2016-2021)
11.9.5 Merck KGaA Recent Development
11.10 Myriad Genetics, Inc.
11.10.1 Myriad Genetics, Inc. Company Details
11.10.2 Myriad Genetics, Inc. Business Overview
11.10.3 Myriad Genetics, Inc. Tumor Genomics Introduction
11.10.4 Myriad Genetics, Inc. Revenue in Tumor Genomics Business (2016-2021)
11.10.5 Myriad Genetics, Inc. Recent Development
11.11 Pacific Biosciences of California, Inc.
11.11.1 Pacific Biosciences of California, Inc. Company Details
11.11.2 Pacific Biosciences of California, Inc. Business Overview
11.11.3 Pacific Biosciences of California, Inc. Tumor Genomics Introduction
11.11.4 Pacific Biosciences of California, Inc. Revenue in Tumor Genomics Business (2016-2021)
11.11.5 Pacific Biosciences of California, Inc. Recent Development
11.12 PerkinElmer
11.12.1 PerkinElmer Company Details
11.12.2 PerkinElmer Business Overview
11.12.3 PerkinElmer Tumor Genomics Introduction
11.12.4 PerkinElmer Revenue in Tumor Genomics Business (2016-2021)
11.12.5 PerkinElmer Recent Development
11.13 QIAGEN
11.13.1 QIAGEN Company Details
11.13.2 QIAGEN Business Overview
11.13.3 QIAGEN Tumor Genomics Introduction
11.13.4 QIAGEN Revenue in Tumor Genomics Business (2016-2021)
11.13.5 QIAGEN Recent Development
11.14 Siemens Healthineers AG
11.14.1 Siemens Healthineers AG Company Details
11.14.2 Siemens Healthineers AG Business Overview
11.14.3 Siemens Healthineers AG Tumor Genomics Introduction
11.14.4 Siemens Healthineers AG Revenue in Tumor Genomics Business (2016-2021)
11.14.5 Siemens Healthineers AG Recent Development
11.15 Thermo Fisher Scientific Inc.
11.15.1 Thermo Fisher Scientific Inc. Company Details
11.15.2 Thermo Fisher Scientific Inc. Business Overview
11.15.3 Thermo Fisher Scientific Inc. Tumor Genomics Introduction
11.15.4 Thermo Fisher Scientific Inc. Revenue in Tumor Genomics Business (2016-2021)
11.15.5 Thermo Fisher Scientific Inc. Recent Development
12 Analyst’s Viewpoints/Conclusions
13 Appendix
13.1 Research Methodology
13.1.1 Methodology/Research Approach
13.1.2 Data Source
13.2 Disclaimer
13.3 Author Details
Table 1. Global Tumor Genomics Market Size Growth Rate by Type (US$ Million):2016 VS 2021 VS 2027
Table 2. Key Players of Assays and Kits
Table 3. Key Players of Instrument
Table 4. Global Tumor Genomics Market Size Growth by Application (US$ Million): 2016 VS 2021 VS 2027
Table 5. Global Tumor Genomics Market Size by Regions (US$ Million): 2016 VS 2021 VS 2027
Table 6. Global Tumor Genomics Market Size by Regions (2016-2021) & (US$ Million)
Table 7. Global Tumor Genomics Market Share by Regions (2016-2021)
Table 8. Global Tumor Genomics Forecasted Market Size by Regions (2022-2027) & (US$ Million)
Table 9. Global Tumor Genomics Market Share by Regions (2022-2027)
Table 10. Tumor Genomics Market Trends
Table 11. Tumor Genomics Market Drivers
Table 12. Tumor Genomics Market Challenges
Table 13. Tumor Genomics Market Restraints
Table 14. Global Tumor Genomics Revenue by Players (2016-2021) & (US$ Million)
Table 15. Global Tumor Genomics Market Share by Players (2016-2021)
Table 16. Global Top Tumor Genomics Players by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Tumor Genomics as of 2020)
Table 17. Ranking of Global Top Tumor Genomics Companies by Revenue (US$ Million) in 2020
Table 18. Global 5 Largest Players Market Share by Tumor Genomics Revenue (CR5 and HHI) & (2016-2021)
Table 19. Key Players Headquarters and Area Served
Table 20. Key Players Tumor Genomics Product Solution and Service
Table 21. Date of Enter into Tumor Genomics Market
Table 22. Mergers & Acquisitions, Expansion Plans
Table 23. Global Tumor Genomics Market Size by Type (2016-2021) (US$ Million)
Table 24. Global Tumor Genomics Revenue Market Share by Type (2016-2021)
Table 25. Global Tumor Genomics Forecasted Market Size by Type (2022-2027) (US$ Million)
Table 26. Global Tumor Genomics Revenue Market Share by Type (2022-2027) & (US$ Million)
Table 27. Global Tumor Genomics Market Size Share by Application (2016-2021) & (US$ Million)
Table 28. Global Tumor Genomics Revenue Market Share by Application (2016-2021)
Table 29. Global Tumor Genomics Forecasted Market Size by Application (2022-2027) (US$ Million)
Table 30. Global Tumor Genomics Revenue Market Share by Application (2022-2027) & (US$ Million)
Table 31. North America Tumor Genomics Market Size by Type (2016-2021) (US$ Million)
Table 32. North America Tumor Genomics Market Size by Type (2022-2027) & (US$ Million)
Table 33. North America Tumor Genomics Market Size by Application (2016-2021) (US$ Million)
Table 34. North America Tumor Genomics Market Size by Application (2022-2027) & (US$ Million)
Table 35. North America Tumor Genomics Market Size by Country (2016-2021) & (US$ Million)
Table 36. North America Tumor Genomics Market Size by Country (2022-2027) & (US$ Million)
Table 37. Europe Tumor Genomics Market Size by Type (2016-2021) (US$ Million)
Table 38. Europe Tumor Genomics Market Size by Type (2022-2027) & (US$ Million)
Table 39. Europe Tumor Genomics Market Size by Application (2016-2021) (US$ Million)
Table 40. Europe Tumor Genomics Market Size by Application (2022-2027) & (US$ Million)
Table 41. Europe Tumor Genomics Market Size by Country (2016-2021) & (US$ Million)
Table 42. Europe Tumor Genomics Market Size by Country (2022-2027) & (US$ Million)
Table 43. Asia-Pacific Tumor Genomics Market Size by Type (2016-2021) (US$ Million)
Table 44. Asia-Pacific Tumor Genomics Market Size by Type (2022-2027) & (US$ Million)
Table 45. Asia-Pacific Tumor Genomics Market Size by Application (2016-2021) (US$ Million)
Table 46. Asia-Pacific Tumor Genomics Market Size by Application (2022-2027) & (US$ Million)
Table 47. Asia-Pacific Tumor Genomics Market Size by Region (2016-2021) & (US$ Million)
Table 48. Asia-Pacific Tumor Genomics Market Size by Region (2022-2027) & (US$ Million)
Table 49. Latin America Tumor Genomics Market Size by Type (2016-2021) (US$ Million)
Table 50. Latin America Tumor Genomics Market Size by Type (2022-2027) & (US$ Million)
Table 51. Latin America Tumor Genomics Market Size by Application (2016-2021) (US$ Million)
Table 52. Latin America Tumor Genomics Market Size by Application (2022-2027) & (US$ Million)
Table 53. Latin America Tumor Genomics Market Size by Country (2016-2021) & (US$ Million)
Table 54. Latin America Tumor Genomics Market Size by Country (2022-2027) & (US$ Million)
Table 55. Middle East & Africa Tumor Genomics Market Size by Type (2016-2021) (US$ Million)
Table 56. Middle East & Africa Tumor Genomics Market Size by Type (2022-2027) & (US$ Million)
Table 57. Middle East & Africa Tumor Genomics Market Size by Application (2016-2021) (US$ Million)
Table 58. Middle East & Africa Tumor Genomics Market Size by Application (2022-2027) & (US$ Million)
Table 59. Middle East & Africa Tumor Genomics Market Size by Country (2016-2021) & (US$ Million)
Table 60. Middle East & Africa Tumor Genomics Market Size by Country (2022-2027) & (US$ Million)
Table 61. Abbott Laboratories Company Details
Table 62. Abbott Laboratories Business Overview
Table 63. Abbott Laboratories Tumor Genomics Product
Table 64. Abbott Laboratories Revenue in Tumor Genomics Business (2016-2021) & (US$ Million)
Table 65. Abbott Laboratories Recent Development
Table 66. Agilent Technologies, Inc Company Details
Table 67. Agilent Technologies, Inc Business Overview
Table 68. Agilent Technologies, Inc Tumor Genomics Product
Table 69. Agilent Technologies, Inc Revenue in Tumor Genomics Business (2016-2021) & (US$ Million)
Table 70. Agilent Technologies, Inc Recent Development
Table 71. Bio-Rad Laboratories, Inc. Company Details
Table 72. Bio-Rad Laboratories, Inc. Business Overview
Table 73. Bio-Rad Laboratories, Inc. Tumor Genomics Product
Table 74. Bio-Rad Laboratories, Inc. Revenue in Tumor Genomics Business (2016-2021) & (US$ Million)
Table 75. Bio-Rad Laboratories, Inc. Recent Development
Table 76. Danaher Corporation Company Details
Table 77. Danaher Corporation Business Overview
Table 78. Danaher Corporation Tumor Genomics Product
Table 79. Danaher Corporation Revenue in Tumor Genomics Business (2016-2021) & (US$ Million)
Table 80. Danaher Corporation Recent Development
Table 81. F. Hoffmann-La Roche Ltd Company Details
Table 82. F. Hoffmann-La Roche Ltd Business Overview
Table 83. F. Hoffmann-La Roche Ltd Tumor Genomics Product
Table 84. F. Hoffmann-La Roche Ltd Revenue in Tumor Genomics Business (2016-2021) & (US$ Million)
Table 85. F. Hoffmann-La Roche Ltd Recent Development
Table 86. Fluidigm Corporation Company Details
Table 87. Fluidigm Corporation Business Overview
Table 88. Fluidigm Corporation Tumor Genomics Product
Table 89. Fluidigm Corporation Revenue in Tumor Genomics Business (2016-2021) & (US$ Million)
Table 90. Fluidigm Corporation Recent Development
Table 91. General Electric Company Company Details
Table 92. General Electric Company Business Overview
Table 93. General Electric Company Tumor Genomics Product
Table 94. General Electric Company Revenue in Tumor Genomics Business (2016-2021) & (US$ Million)
Table 95. General Electric Company Recent Development
Table 96. Illumina, Inc. Company Details
Table 97. Illumina, Inc. Business Overview
Table 98. Illumina, Inc. Revenue in Tumor Genomics Business (2016-2021) & (US$ Million)
Table 99. Illumina, Inc. Recent Development
Table 100. Merck KGaA Company Details
Table 101. Merck KGaA Business Overview
Table 102. Merck KGaA Tumor Genomics Product
Table 103. Merck KGaA Revenue in Tumor Genomics Business (2016-2021) & (US$ Million)
Table 104. Merck KGaA Recent Development
Table 105. Myriad Genetics, Inc. Company Details
Table 106. Myriad Genetics, Inc. Business Overview
Table 107. Myriad Genetics, Inc. Tumor Genomics Product
Table 108. Myriad Genetics, Inc. Revenue in Tumor Genomics Business (2016-2021) & (US$ Million)
Table 109. Myriad Genetics, Inc. Recent Development
Table 110. Pacific Biosciences of California, Inc. Company Details
Table 111. Pacific Biosciences of California, Inc. Business Overview
Table 112. Pacific Biosciences of California, Inc. Tumor Genomics Product
Table 113. Pacific Biosciences of California, Inc. Revenue in Tumor Genomics Business (2016-2021) & (US$ Million)
Table 114. Pacific Biosciences of California, Inc. Recent Development
Table 115. PerkinElmer Company Details
Table 116. PerkinElmer Business Overview
Table 117. PerkinElmer Tumor Genomics Product
Table 118. PerkinElmer Revenue in Tumor Genomics Business (2016-2021) & (US$ Million)
Table 119. PerkinElmer Recent Development
Table 120. QIAGEN Company Details
Table 121. QIAGEN Business Overview
Table 122. QIAGEN Tumor Genomics Product
Table 123. QIAGEN Revenue in Tumor Genomics Business (2016-2021) & (US$ Million)
Table 124. QIAGEN Recent Development
Table 125. Siemens Healthineers AG Company Details
Table 126. Siemens Healthineers AG Business Overview
Table 127. Siemens Healthineers AG Tumor Genomics Product
Table 128. Siemens Healthineers AG Revenue in Tumor Genomics Business (2016-2021) & (US$ Million)
Table 129. Siemens Healthineers AG Recent Development
Table 130. Thermo Fisher Scientific Inc. Company Details
Table 131. Thermo Fisher Scientific Inc. Business Overview
Table 132. Thermo Fisher Scientific Inc. Tumor Genomics Product
Table 133. Thermo Fisher Scientific Inc. Revenue in Tumor Genomics Business (2016-2021) & (US$ Million)
Table 134. Thermo Fisher Scientific Inc. Recent Development
Table 135. Research Programs/Design for This Report
Table 136. Key Data Information from Secondary Sources
Table 137. Key Data Information from Primary Sources
List of Figures
Figure 1. Global Tumor Genomics Market Share by Type: 2020 VS 2027
Figure 2. Assays and Kits Features
Figure 3. Instrument Features
Figure 4. Global Tumor Genomics Market Share by Application: 2020 VS 2027
Figure 5. Diagnostics and Monitoring Case Studies
Figure 6. Drug Discovery and Development Case Studies
Figure 7. Biomarker Discovery Case Studies
Figure 8. Tumor Genomics Report Years Considered
Figure 9. Global Tumor Genomics Market Size (US$ Million), Year-over-Year: 2016-2027
Figure 10. Global Tumor Genomics Market Size (US$ Million), 2016 VS 2021 VS 2027
Figure 11. Global Tumor Genomics Market Share by Regions: 2020 VS 2027
Figure 12. Global Tumor Genomics Market Share by Regions (2022-2027)
Figure 13. Global Tumor Genomics Market Share by Players in 2020
Figure 14. Global Top Tumor Genomics Players by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Tumor Genomics as of 2020
Figure 15. The Top 10 and 5 Players Market Share by Tumor Genomics Revenue in 2020
Figure 16. Global Tumor Genomics Revenue Market Share by Type (2016-2021)
Figure 17. Global Tumor Genomics Revenue Market Share by Type (2022-2027)
Figure 18. North America Tumor Genomics Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 19. North America Tumor Genomics Market Share by Type (2016-2027)
Figure 20. North America Tumor Genomics Market Share by Application (2016-2027)
Figure 21. North America Tumor Genomics Market Share by Country (2016-2027)
Figure 22. United States Tumor Genomics Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 23. Canada Tumor Genomics Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 24. Europe Tumor Genomics Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 25. Europe Tumor Genomics Market Share by Type (2016-2027)
Figure 26. Europe Tumor Genomics Market Share by Application (2016-2027)
Figure 27. Europe Tumor Genomics Market Share by Country (2016-2027)
Figure 28. Germany Tumor Genomics Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 29. France Tumor Genomics Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 30. U.K. Tumor Genomics Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 31. Italy Tumor Genomics Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 32. Russia Tumor Genomics Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 33. Nordic Tumor Genomics Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 34. Asia-Pacific Tumor Genomics Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 35. Asia-Pacific Tumor Genomics Market Share by Type (2016-2027)
Figure 36. Asia-Pacific Tumor Genomics Market Share by Application (2016-2027)
Figure 37. Asia-Pacific Tumor Genomics Market Share by Region (2016-2027)
Figure 38. China Tumor Genomics Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 39. Japan Tumor Genomics Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 40. South Korea Tumor Genomics Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 41. Southeast Asia Tumor Genomics Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 42. India Tumor Genomics Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 43. Australia Tumor Genomics Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 44. Latin America Tumor Genomics Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 45. Latin America Tumor Genomics Market Share by Type (2016-2027)
Figure 46. Latin America Tumor Genomics Market Share by Application (2016-2027)
Figure 47. Latin America Tumor Genomics Market Share by Country (2016-2027)
Figure 48. Mexico Tumor Genomics Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 49. Brazil Tumor Genomics Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 50. Middle East & Africa Tumor Genomics Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 51. Middle East & Africa Tumor Genomics Market Share by Type (2016-2027)
Figure 52. Middle East & Africa Tumor Genomics Market Share by Application (2016-2027)
Figure 53. Middle East & Africa Tumor Genomics Market Share by Country (2016-2027)
Figure 54. Turkey Tumor Genomics Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 55. Saudi Arabia Tumor Genomics Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 56. UAE Tumor Genomics Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 57. Abbott Laboratories Revenue Growth Rate in Tumor Genomics Business (2016-2021)
Figure 58. Agilent Technologies, Inc Revenue Growth Rate in Tumor Genomics Business (2016-2021)
Figure 59. Bio-Rad Laboratories, Inc. Revenue Growth Rate in Tumor Genomics Business (2016-2021)
Figure 60. Danaher Corporation Revenue Growth Rate in Tumor Genomics Business (2016-2021)
Figure 61. F. Hoffmann-La Roche Ltd Revenue Growth Rate in Tumor Genomics Business (2016-2021)
Figure 62. Fluidigm Corporation Revenue Growth Rate in Tumor Genomics Business (2016-2021)
Figure 63. General Electric Company Revenue Growth Rate in Tumor Genomics Business (2016-2021)
Figure 64. Illumina, Inc. Revenue Growth Rate in Tumor Genomics Business (2016-2021)
Figure 65. Merck KGaA Revenue Growth Rate in Tumor Genomics Business (2016-2021)
Figure 66. Myriad Genetics, Inc. Revenue Growth Rate in Tumor Genomics Business (2016-2021)
Figure 67. Pacific Biosciences of California, Inc. Revenue Growth Rate in Tumor Genomics Business (2016-2021)
Figure 68. PerkinElmer Revenue Growth Rate in Tumor Genomics Business (2016-2021)
Figure 69. QIAGEN Revenue Growth Rate in Tumor Genomics Business (2016-2021)
Figure 70. Siemens Healthineers AG Revenue Growth Rate in Tumor Genomics Business (2016-2021)
Figure 71. Thermo Fisher Scientific Inc. Revenue Growth Rate in Tumor Genomics Business (2016-2021)
Figure 72. Bottom-up and Top-down Approaches for This Report
Figure 73. Data Triangulation
Figure 74. Key Executives Interviewed
世界のがん腫瘍プロファイリング市場規模・現状・予測（2021年-2027年） Cancer/tumor profiling provides information about the genes causing cancer, which would offer useful insights related to the mechanism of cancer. The potential of cancer profiling is not only limited to common cancers, such as lymphoma and breast cancer, but also is useful in molecular profiling of …- 世界の医薬品開発＆創薬用人工知能市場規模・現状・予測（2021年-2027年） Market Analysis and Insights: Global Artificial Intelligence For Drug Development and Discovery Market The global Artificial Intelligence For Drug Development and Discovery market size is projected to reach US$ XX million by 2027, from US$ XX million in 2020, at a CAGR of XX% during 2021-2027. With …
- 世界の消化管間質腫瘍分子診断市場規模・現状・予測（2021年-2027年） A method for diagnosing gastrointestinal Stromal Tumor Market Analysis and Insights: Global Gastrointestinal Stromal Tumor Molecular Diagnostics Market The global Gastrointestinal Stromal Tumor Molecular Diagnostics market size is projected to reach US$ XX million by 2027, from US$ XX million in 202…
- 世界の腫瘍特異抗原市場規模・現状・予測（2021年-2027年） Tumor-specific Antigen is a new Antigen that is expressed on the surface of certain Tumor cells but not on normal cells.Such antigens may be present in tumors of the same tissue type in different individuals.Tumor-specific antigens help the body develop an immune response to cancer cells.They could …
- 世界の胆管腫瘍市場規模・現状・予測（2021年-2027年） Biliary Tumor is a form of cancer that develops in the bile duct system, which connects the liver, gallbladder, and small intestine, moving bile – a fluid that helps digest fats – to the small intestine. Market Analysis and Insights: Global Biliary Tumor Market The global Biliary Tumor market size i…